-
Product Insights
Power China Construction Yinggehai Salt Field Solar PV Park
Power China Construction Yinggehai Salt Field Solar PV Park is a solar PV project located in Hainan, China. The project is being developed by PowerChina Central China Electric Power Engineering Co Ltd. The project is expected to come online in 2026. Empower your strategies with our Power China Construction Yinggehai Salt Field Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within...
-
Company Insights
Innovation and Patenting activity of Qinghai Salt Lake Industry Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Qinghai Salt Lake Industry Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PF-07899895 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PF-07899895 in Ulcerative Colitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PF-07899895 in Ulcerative Colitis Drug Details: PF-07899895 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Histamine Dihydrochloride in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Histamine Dihydrochloride in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Histamine Dihydrochloride in Alzheimer's Disease Drug Details: Histamine dihydrochloride is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Histamine Dihydrochloride in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Histamine Dihydrochloride in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Histamine Dihydrochloride in Epilepsy Drug Details: Histamine dihydrochloride is under development of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Histamine Dihydrochloride in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Histamine Dihydrochloride in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Histamine Dihydrochloride in Parkinson's Disease Drug Details: Histamine dihydrochloride is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Histamine Dihydrochloride in Schizophrenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Histamine Dihydrochloride in Schizophrenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Histamine Dihydrochloride in Schizophrenia Drug Details: Histamine dihydrochloride is under development of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – T-817MA in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - T-817MA in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. T-817MA in Alzheimer's Disease Drug Details: T-817MA is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HTD-1801 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HTD-1801 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HTD-1801 in Type 2 Diabetes Drug Details: HTD-1801 (berberine ursodeoxycholate) is...